Prospective cohort study of early predictive markers of outcome in hepatocellular carcinoma patients after transcatheter arterial chemoembolization (TACE)

Prospective cohort study of early predictive markers of outcome in hepatocellular carcinoma patients after transcatheter arterial chemoembolization (TACE) - Prospective cohort study of early predictive markers of outcome in HCC after TACE

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004273

Enrollment

110

Registered

2010-09-30

Start date

2008-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma

Interventions

Indirect calorimetry in pre-TACE and 7 days after TACE

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients who were not adapted to the exclusion criteria were treated with segmental TACE.

Exclusion criteria

Exclusion criteria: Those who had refractory ascites, overt hepatic encephalopathy, uncontrolled esophageal varices, severe jaundice, Child's grade C and portal vein trunk thrombosis were excluded from the study. In addition, those who used intravenous albumin regularly were also excluded.

Design outcomes

Primary

Measure	Time frame
The deterioration of Child's score and the development of ascites 3 months after to before TACE	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026